Cargando…
DNA framework-engineered chimeras platform enables selectively targeted protein degradation
A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372072/ https://www.ncbi.nlm.nih.gov/pubmed/37495569 http://dx.doi.org/10.1038/s41467-023-40244-7 |
_version_ | 1785078289589600256 |
---|---|
author | Zhou, Li Yu, Bin Gao, Mengqiu Chen, Rui Li, Zhiyu Gu, Yueqing Bian, Jinlei Ma, Yi |
author_facet | Zhou, Li Yu, Bin Gao, Mengqiu Chen, Rui Li, Zhiyu Gu, Yueqing Bian, Jinlei Ma, Yi |
author_sort | Zhou, Li |
collection | PubMed |
description | A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalent DNA framework-based PROTACs (DbTACs), which can be synthesized in high-throughput via facile bioorthogonal chemistry and self-assembly. DNA tetrahedra are employed as templates and the spatial position of each atom is defined. Thus, by precisely locating ligands of POI and E3 ligase on the templates, ligand spacings can be controllably manipulated from 8 Å to 57 Å. We show that DbTACs with the optimal linker length between ligands achieve higher degradation rates and enhanced binding affinity. Bispecific DbTACs (bis-DbTACs) with trivalent ligand assembly enable multi-target depletion while maintaining highly selective degradation of protein subtypes. When employing various types of warheads (small molecules, antibodies, and DNA motifs), DbTACs exhibit robust efficacy in degrading diverse targets, including protein kinases and transcription factors located in different cellular compartments. Overall, utilizing modular DNA frameworks to conjugate substrates offers a universal platform that not only provides insight into general degrader design principles but also presents a promising strategy for guiding drug discovery. |
format | Online Article Text |
id | pubmed-10372072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103720722023-07-28 DNA framework-engineered chimeras platform enables selectively targeted protein degradation Zhou, Li Yu, Bin Gao, Mengqiu Chen, Rui Li, Zhiyu Gu, Yueqing Bian, Jinlei Ma, Yi Nat Commun Article A challenge in developing proteolysis targeting chimeras (PROTACs) is the establishment of a universal platform applicable in multiple scenarios for precise degradation of proteins of interest (POIs). Inspired by the addressability, programmability, and rigidity of DNA frameworks, we develop covalent DNA framework-based PROTACs (DbTACs), which can be synthesized in high-throughput via facile bioorthogonal chemistry and self-assembly. DNA tetrahedra are employed as templates and the spatial position of each atom is defined. Thus, by precisely locating ligands of POI and E3 ligase on the templates, ligand spacings can be controllably manipulated from 8 Å to 57 Å. We show that DbTACs with the optimal linker length between ligands achieve higher degradation rates and enhanced binding affinity. Bispecific DbTACs (bis-DbTACs) with trivalent ligand assembly enable multi-target depletion while maintaining highly selective degradation of protein subtypes. When employing various types of warheads (small molecules, antibodies, and DNA motifs), DbTACs exhibit robust efficacy in degrading diverse targets, including protein kinases and transcription factors located in different cellular compartments. Overall, utilizing modular DNA frameworks to conjugate substrates offers a universal platform that not only provides insight into general degrader design principles but also presents a promising strategy for guiding drug discovery. Nature Publishing Group UK 2023-07-27 /pmc/articles/PMC10372072/ /pubmed/37495569 http://dx.doi.org/10.1038/s41467-023-40244-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zhou, Li Yu, Bin Gao, Mengqiu Chen, Rui Li, Zhiyu Gu, Yueqing Bian, Jinlei Ma, Yi DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title | DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title_full | DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title_fullStr | DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title_full_unstemmed | DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title_short | DNA framework-engineered chimeras platform enables selectively targeted protein degradation |
title_sort | dna framework-engineered chimeras platform enables selectively targeted protein degradation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372072/ https://www.ncbi.nlm.nih.gov/pubmed/37495569 http://dx.doi.org/10.1038/s41467-023-40244-7 |
work_keys_str_mv | AT zhouli dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT yubin dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT gaomengqiu dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT chenrui dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT lizhiyu dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT guyueqing dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT bianjinlei dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation AT mayi dnaframeworkengineeredchimerasplatformenablesselectivelytargetedproteindegradation |